1ZTS:BIT
Zoetis Inc
€61.60
arrow_downward
-0.93%(-0.58) 1D
Oct 2, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Yahoo Finance
·
37 minutes ago
Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug
ad-hoc-news.de
·
5 hours ago
Zoetis appoints Iris Knobloch to board as Zoetis stock holds value
The Globe and Mail
·
12 hours ago
3 Reasons ZTS is Risky and 1 Stock to Buy Instead
Simply Wall Street
·
1 day ago
Zoetis (ZTS) Stock May Sit Below Fair Value After Mixed Q2 Results
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia